Lumos Pharma Announces New Data and Analysis of 15 Subjects from OraGrowtH212 Trial Presented at the 2023 ESPE Annual Meeting

Related posts

• Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates

  May 8, 2025 GlobeNewswire 0

  Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates

  Source: Medical

  Medical 

• The Foundation for Sarcoidosis Research Expands Board of Directors with Leaders to Help Accelerate Sarcoidosis Research, Advocacy and Patient Support

  May 8, 2025 GlobeNewswire 0

  The Foundation for Sarcoidosis Research Expands Board of Directors with Leaders to Help Accelerate Sarcoidosis Research, Advocacy and Patient Support

  Source: Medical

  Medical 

• New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025

  May 7, 2025 GlobeNewswire 0

  New Preclinical Data for Assembly Biosciences’ Oral Hepatitis D Virus Entry Inhibitor ABI-6250 and Next-Generation Hepatitis B Virus Capsid Assembly Modulator ABI-4334 Presented at the EASL Congress 2025

  Source: Medical

  Medical